Q-Med AB
Sweden SE-MF-000008549 Last updated 23 Oct 2026
Is this your brand? Sign in to claim this brand
- Devices
- 22
- Registries
- EUDAMEDFDA PMAFDA
- FDA recalls
- 0
Catalogue
Restylane Shaype Ref 012337
Restylane Eyelight Ref 012138
Restylane Eyelight Ref 012136
Restylane Shaype Ref 012354
Sculptra Ref 084418
Restylane Shaype Ref 012322
Sculptra Ref 084419
Restylane Lyft Lidocaine Ref 012131
Scuptra Ref 085557
Restylane Refyne Ref 012090
New-Fill Ref 085883
Restylane Skinboosters Vital Light Lidocaine Ref 012093
Restylane Skinboosters Vital Light Lidocaine Ref 012092
Restylane Skinboosters Vital Light Lidocaine Ref 012094
Restylane Skinboosters Vital Lidocaine Ref 012060
Restylane Skinboosters Vital Lidocaine Ref 012061
Restylane Kysse Ref 012062
Restylane Lyft Lidocaine Ref 012129
New-Fill Ref 011263
Restylane Injectable Gel Ref P020023
Sculptra And Sculptra Aesthetic Ref P030050
Restylane, Perlane, Restylane L, Perlane L Ref P040024
Restylane Volyme Ref 012089
EUDAMED certificates
Notified body 0344 4 certificates
- 2268181TD04 Issued
Technical documentation EU MDR
- Issued
- 30 Jul 2026
- Expires
- 1 Jul 2031
- 2268181TD02 Issued
Technical documentation EU MDR
- Issued
- 3 Dec 2025
- Expires
- 1 Dec 2030
- 2268181CE02 Issued
Quality management system EU MDR
- Issued
- 3 Dec 2025
- Expires
- 1 Aug 2030
- 2268181CE04 Issued
Quality management system EU MDR
- Issued
- 30 Jul 2026
- Expires
- 1 Aug 2030
Related companies
Notified bodies
- Notified body 0344
What Q-Med AB makes
Q-Med AB manufactures injectable dermal fillers and skinboosters, including products such as Restylane Skinboosters Vital Light Lidocaine, Restylane Skinboosters Vital Lidocaine, Restylane Kysse, Restylane Lyft Lidocaine, New-Fill, Restylane Injectable Gel, Restylane Refyne and Defyne Injectable Gels, Sculptra and Sculptra Aesthetic, Restylane, Perlane, Restylane L, Perlane L, and Restylane Volyme.
These devices are classified as Class III medical devices and are listed in the EUDAMED and FDA PMA registries. The company is based in Sweden (SE).
Frequently asked questions
What does Q-Med AB manufacture?
Q-Med AB manufactures injectable dermal fillers and skinboosters, including products such as Restylane Skinboosters Vital Light Lidocaine, Restylane Skinboosters Vital Lidocaine, Restylane Kysse, Restylane Lyft Lidocaine, New-Fill, Restylane Injectable Gel, Restylane Refyne and Defyne Injectable Gels, Sculptra and Sculptra Aesthetic, Restylane, Perlane, Restylane L, Perlane L, and Restylane Volyme. These are all injectable gel-based devices intended for dermal implantation.
Where is Q-Med AB based?
Q-Med AB is based in Sweden, as indicated by the country code SE in the manufacturer data. This specifies the country where the company is legally registered and operates from for regulatory purposes.
In which regulatory registries are Q-Med AB's devices listed?
Q-Med AB's devices are listed in the EUDAMED and FDA PMA registries. EUDAMED is the European database for medical devices, and FDA PMA refers to the U.S. Food and Drug Administration's Premarket Approval database for high-risk devices.
How are Q-Med AB's devices classified?
Q-Med AB's devices are classified as Class III medical devices. This classification indicates they are high-risk devices, typically due to their intended use in dermal implantation and prolonged contact with the body, requiring the most stringent regulatory controls.
Information
- Country
- Sweden
- Address
- 21, Seminariegatan, Uppsala, Sweden
- Website
- galderma.com
- [email protected]
- PRRC contact
- Pernilla Styf
- EUDAMED SRN
- SE-MF-000008549
- FDA FEI number
- 3003347293
- DUNS number
- 355371873